Concepedia

Kristian W. Fried

KW

Statistics

Publications

4

Citations

339

H-Index

4

Active since

2001

Affiliations

University of Kansas Medical Center(Current)

Kristian W. Fried is an author at University of Kansas Medical Center specializing in pharmacy, pharmacology, and persistent organic pollutants.

ORCID

Publications per year

2001–2010

4

Publications

4

Terminal elimination half-lives of the brominated flame retardants TBBPA, HBCD, and lower brominated PBDEs in humans

Harald J. Geyer, Karl‐Werner Schramm, Per Ola Darnerud et al. · DORA Empa (Swiss Federal Laboratories for Materials Science and Technology (Empa)) · 2004 · 284 citations

, , +12

2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) reverses hyperglycemia in a type II diabetes mellitus rat model by a mechanism unrelated to PPARγ

Kristian W. Fried, Grace L. Guo, Noriko Esterly et al. · Drug and Chemical Toxicology · 2010 · 23 citations

, , +10

Kinetics of Monochloroacetic Acid in Adult Male Rats after Intravenous Injection of a Subtoxic and a Toxic Dose

Shakil A. Saghir, Kristian W. Fried, Karl K. Rozman · Journal of Pharmacology and Experimental Therapeutics · 2001 · 21 citations

, , +12

From Dioxin to Drug Lead—The Development of 2,3,7,8‐Tetrachlorophenothiazine

Kristian W. Fried, Christopher Schneider, Karl‐Werner Schramm et al. · ChemMedChem · 2007 · 11 citations

, , +11

1–4 of 4